Physician profile
Amanda K Downs
NPI 1518219757
$3,221.09
in general payments reported to CMS, 2019-2025
15 companies · $680 in 2025
The $680 reported for 2025 was more than what 79% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $251 · 2022: $630 · 2023: $879 · 2024: $781 · 2025: $680.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,341.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,340.54 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $1,037.84 | 2022-2025 | Sapien 3 Ultra Resilia, Pascal, Evoque |
| Abiomed | $500.18 | 2022-2024 | Impella |
| Abbott Laboratories | $395.00 | 2021-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Triclip, Navitor |
| Medtronic, INC. | $370.85 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Boston Scientific Corporation | $283.30 | 2022-2024 | Avvigo Guidance System, Watchman Flx, Mamba |
| Janssen Pharmaceuticals, INC | $167.76 | 2021-2025 | Xarelto, Uptravi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $127.12 | 2023-2024 | Jardiance |
| Novartis Pharmaceuticals Corporation | $96.74 | 2023-2024 | |
| Novo Nordisk INC | $62.85 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Shockwave Medical, INC | $43.44 | 2025 | |
| Biosense Webster, INC. | $40.63 | 2025 | Carto 3 |
| E.R. Squibb & Sons, L.L.C. | $30.18 | 2021-2023 | Camzyos |
| Kiniksa Pharmaceuticals International, Plc | $27.44 | 2024 | Arcalyst |
| Amgen INC. | $24.22 | 2022 | |
| Chiesi USA, INC. | $13.54 | 2023 | Cleviprex, Kengreal |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Downs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.